Close Menu

NEW YORK (GenomeWeb) – Exact Sciences announced before the opening of the market on Friday that it is offering $190 million in aggregate principal amount of its 1.0 percent convertible senior notes due 2025. The firm said it expects the offering to provide gross proceeds of $202.4 million.

Exact upsized the offering Friday after originally announcing a $150 million offering after the close of the market on Thursday. The initial public offering price for the Notes will be 106.5 percent of face value plus accrued interest from Jan. 17.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.